stoxline Quote Chart Rank Option Currency Glossary
Vapotherm, Inc. (VAPO)
2.17  -0.1 (-4.41%)    12-06 16:00
Open: 2.27
High: 2.33
Volume: 42,450
Pre. Close: 2.27
Low: 2.17
Market Cap: 13(M)
Technical analysis
2023-12-06 4:24:51 PM
Short term     
Mid term     
Targets 6-month :  3.45 1-year :  4.01
Resists First :  2.95 Second :  3.44
Pivot price 2.63
Supports First :  2.17 Second :  1.8
MAs MA(5) :  2.41 MA(20) :  2.6
MA(100) :  2.87 MA(250) :  5.79
MACD MACD :  -0.1 Signal :  -0.1
%K %D K(14,3) :  2.7 D(3) :  10
RSI RSI(14): 37.2
52-week High :  23.68 Low :  2.17
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ VAPO ] has closed above bottom band by 8.5%. Bollinger Bands are 36.1% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 2.35 - 2.37 2.37 - 2.38
Low: 2.12 - 2.15 2.15 - 2.17
Close: 2.14 - 2.18 2.18 - 2.21
Company Description

Vapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers precision flow systems, such as Precision Flow Hi-VNI, Precision Flow Plus, Precision Flow Classic, and Precision Flow Heliox that deliver heated, humidified, and oxygenated air at a high velocity to patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor, which provides compressed air necessary to run the precision flow systems; aerosol aeroneb adaptor to facilitate delivery of ultrasonic aerosolized medication; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol medication; and tracheostomy adaptors. In addition, Vapotherm, Inc. offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Modules, which helps clinicians maintain oxygen levels within a target range. The company sells its products to hospitals. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire.

Headline News

Fri, 10 Nov 2023
Vapotherm, Inc. (NYSE:VAPO) Q3 2023 Earnings Call Transcript - Yahoo Finance

Wed, 08 Nov 2023
Vapotherm: Q3 Earnings Snapshot - Houston Chronicle

Wed, 08 Nov 2023
Vapotherm: Q3 Earnings Snapshot - San Francisco Chronicle

Wed, 04 Oct 2023
Computational Fluid Dynamics (CFD) modeling further distinguishes Vapotherm High Velocity Therapy from generic ... - Business Wire

Mon, 25 Sep 2023
Pilot Study demonstrates Vapotherm HVNI technology is more effective than standard oxygen therapy for treatment of ... - Business Wire

Wed, 08 Feb 2023
Vapotherm Announces $23 Million Private Placement - Business Wire

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Stock Basics & Statistics
Medical Devices
Shares Out 6 (M)
Shares Float 3 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 491 (K)
Shares Short P.Month 326 (K)
Stock Financials
EPS -14.33
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -7.74
Profit Margin -102.8 %
Operating Margin -62.8 %
Return on Assets (ttm) -31.4 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 12 %
Gross Profit (p.s.) 2.96
Sales Per Share 11
EBITDA (p.s.) -7.12
Qtrly Earnings Growth 0 %
Operating Cash Flow -31 (M)
Levered Free Cash Flow -22 (M)
Stock Valuations
PE Ratio -0.16
PEG Ratio -0.1
Price to Book value -0.29
Price to Sales 0.19
Price to Cash Flow -0.43
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android